Correlate of immune protection against HSV-1 genital disease in vaccinated women (Q37604473)

21 August 2017

Correlate of immune protection against HSV-1 genital disease in vaccinated women (English)

1 reference

Herpes simplex virus type 1

21 August 2017

1 reference

1

Robert B Belshe

1 reference

21 August 2017

4

Abbie R Bellamy

1 reference

21 August 2017

3

David I Bernstein

1 reference

21 August 2017

Thomas C Heineman

2

1 reference

21 August 2017

Marian Ewell

series ordinal

5

1 reference

21 August 2017

Robbert van der Most

series ordinal

6

1 reference

21 August 2017

Carolyn D Deal

series ordinal

7

1 reference

21 August 2017

language of work or name

English

0 references

publication date

27 November 2013

1 reference

Journal of Infectious Diseases

21 August 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 August 2017

209

1 reference

21 August 2017

828-836

1 reference

21 August 2017

6

1 reference

Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3935479

Efficacy results of a trial of a herpes simplex vaccine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3935479

Immunofluorescence analysis of T-cell responses in health and disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3935479

Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3935479

Inability of Enzyme Immunoassays to Discriminate between Infections with Herpes Simplex Virus Types 1 and 2

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3935479

A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3935479

Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3935479

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3935479

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24285844

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIT651

1 reference

21 August 2017

1 reference

21 August 2017

1 reference